Harry Spiera

3.2k total citations
93 papers, 2.3k citations indexed

About

Harry Spiera is a scholar working on Rheumatology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Harry Spiera has authored 93 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Rheumatology, 20 papers in Pathology and Forensic Medicine and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Harry Spiera's work include Systemic Lupus Erythematosus Research (20 papers), Systemic Sclerosis and Related Diseases (18 papers) and Vasculitis and related conditions (12 papers). Harry Spiera is often cited by papers focused on Systemic Lupus Erythematosus Research (20 papers), Systemic Sclerosis and Related Diseases (18 papers) and Vasculitis and related conditions (12 papers). Harry Spiera collaborates with scholars based in United States, Germany and Japan. Harry Spiera's co-authors include Leslie Dubin Kerr, Constantin A. Bona, Robert Spiera, Tracy L. McGaha, Robert Phelps, Hal J. Mitnick, S A Paget, Mark J. Kupersmith, J. Ritter and Norman L. Gershfeld and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of the American Chemical Society.

In The Last Decade

Harry Spiera

92 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harry Spiera United States 29 807 540 490 385 363 93 2.3k
Stefano Bombardieri Italy 30 883 1.1× 804 1.5× 290 0.6× 692 1.8× 438 1.2× 88 3.3k
Francesco Trotta Italy 36 1.9k 2.4× 523 1.0× 343 0.7× 535 1.4× 891 2.5× 154 3.6k
B Freundlich United States 25 1.1k 1.4× 345 0.6× 241 0.5× 750 1.9× 809 2.2× 46 3.1k
Sylvain Dubucquoi France 29 1.1k 1.3× 745 1.4× 288 0.6× 403 1.0× 856 2.4× 130 3.0k
P J Roberts-Thomson Australia 38 1.5k 1.8× 1.0k 1.9× 541 1.1× 374 1.0× 1.0k 2.8× 185 4.0k
Mimi Høier‐Madsen Denmark 26 621 0.8× 369 0.7× 144 0.3× 345 0.9× 358 1.0× 101 2.2k
Nicole Fabien France 35 764 0.9× 411 0.8× 388 0.8× 512 1.3× 894 2.5× 146 3.7k
D M Grennan United Kingdom 25 1.1k 1.3× 226 0.4× 149 0.3× 362 0.9× 960 2.6× 113 2.5k
Roberta Priori Italy 37 1.3k 1.6× 420 0.8× 263 0.5× 788 2.0× 885 2.4× 158 3.9k
Giampaola Pesce Italy 30 263 0.3× 326 0.6× 305 0.6× 240 0.6× 705 1.9× 111 2.6k

Countries citing papers authored by Harry Spiera

Since Specialization
Citations

This map shows the geographic impact of Harry Spiera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Spiera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Spiera more than expected).

Fields of papers citing papers by Harry Spiera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Spiera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Spiera. The network helps show where Harry Spiera may publish in the future.

Co-authorship network of co-authors of Harry Spiera

This figure shows the co-authorship network connecting the top 25 collaborators of Harry Spiera. A scholar is included among the top collaborators of Harry Spiera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry Spiera. Harry Spiera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McGaha, Tracy L., Takao Kodera, Harry Spiera, et al.. (2002). Halofuginone inhibition of COL1A2 promoter activity via a c‐Jun–dependent mechanism. Arthritis & Rheumatism. 46(10). 2748–2761. 33 indexed citations
2.
Tan, Filemon K., Frank C. Arnett, Shinichiro Saito, et al.. (1999). Autoantibodies to the Extracellular Matrix Microfibrillar Protein, Fibrillin-1, in Patients with Scleroderma and Other Connective Tissue Diseases. The Journal of Immunology. 163(2). 1066–1072. 102 indexed citations
3.
Caplin, Nina, Steven Dikman, Jonathan Winston, Harry Spiera, & Jaime Uribarri. (1999). Recurrence of scleroderma in a renal allograft from an identical twin sister. American Journal of Kidney Diseases. 33(4). e7.1–e7.4. 9 indexed citations
4.
Langer, Ruth, et al.. (1999). Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy. British Journal of Ophthalmology. 83(7). 796–801. 21 indexed citations
5.
Jaffin, Barry W., Peter Chang, & Harry Spiera. (1997). Fecal Incontinence in Scleroderma. Journal of Clinical Gastroenterology. 25(3). 513–517. 38 indexed citations
6.
7.
Healey, John H., Stephen A. Paget, Pamela Williams‐Russo, et al.. (1996). A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica. Calcified Tissue International. 58(2). 73–80. 79 indexed citations
8.
Shapiro, Deborah L. & Harry Spiera. (1995). Regression of the nephrotic syndrome in rheumatoid arthritis and amyloidosis treated with azathioprine. Arthritis & Rheumatism. 38(12). 1851–1854. 23 indexed citations
9.
Ornstein, M H, et al.. (1994). Correlation of Liver and Skin Histopathology With Serology in a Patient With Cutaneous Vasculitis and Hepatitis C Infection. Southern Medical Journal. 87(11). 1174–1177. 4 indexed citations
10.
Fillit, Howard, S Shibata, Takeshi Sasaki, et al.. (1993). Autoantibodies to the Protein Core of Vascular Basement Membrane Heparan Sulfate Proteoglycan in Systemic Lupus Erythematosus. Autoimmunity. 14(3). 243–249. 25 indexed citations
11.
Copeland, Michelle, et al.. (1993). Systemic Inflammatory Disorder Related to Fibrous Breast Capsules after Silicone Implant Removal. Plastic & Reconstructive Surgery. 92(6). 1179–1181. 17 indexed citations
12.
Hanson, Veneta, et al.. (1992). Systemic lupus erythematosus patients with central nervous system involvement show autoantibodies to a 50-kD neuronal membrane protein.. The Journal of Experimental Medicine. 176(2). 565–573. 45 indexed citations
13.
Dikman, Steven, et al.. (1991). Recovery of Renal Function in Undifferentiated Connective Tissue Disease After Treatment With Angiotensin-Converting Enzyme Inhibitors. American Journal of Kidney Diseases. 18(6). 716–719. 3 indexed citations
14.
Spiera, Harry. (1990). Giant Cell Arteritis and Polymyalgia Rheumatica. Hospital Practice. 25(11). 71–88. 3 indexed citations
15.
Kerr, Leslie Dubin, et al.. (1989). Factor B activation products in patients with systemic lupus erythematosus. A marker of severe disease activity. Arthritis & Rheumatism. 32(11). 1406–1413. 27 indexed citations
16.
Spiera, Harry, et al.. (1986). Complement activation in systemic lupus erythematosus: a marker of inflammation.. PubMed. 13(2). 313–9. 13 indexed citations
17.
Meyers, Sanford M., Steven Dikman, Harry Spiera, Nikolaus Schultz, & Henry D. Janowitz. (1981). Cutaneous vasculitis complicating coeliac disease.. Gut. 22(1). 61–64. 48 indexed citations
18.
Spiera, Harry, et al.. (1971). A DIETARY REGIMEN IN THE TREATMENT OF PSORIASIS. British Journal of Dermatology. 85(3). 277–285. 3 indexed citations
19.
Spiera, Harry, et al.. (1970). Autoerythrocyte sensitization reproductible by both autologous red cells and heterologous DNA.. PubMed. 37(2). 108–11. 6 indexed citations
20.
Spiera, Harry, et al.. (1967). REMISSION OF PSORIASIS WITH LOW DIETARY TRYPTOPHAN. The Lancet. 290(7507). 137–139. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefano Bombardieri Breakdown of academic impact, for papers by Francesco Trotta Breakdown of academic impact, for papers by B Freundlich Breakdown of academic impact, for papers by Sylvain Dubucquoi Breakdown of academic impact, for papers by P J Roberts-Thomson Breakdown of academic impact, for papers by Mimi Høier‐Madsen Breakdown of academic impact, for papers by Nicole Fabien Breakdown of academic impact, for papers by D M Grennan Breakdown of academic impact, for papers by Roberta Priori Breakdown of academic impact, for papers by Giampaola Pesce
Rankless by CCL
2026